Fosun International LTD Amarin Corp Plcuk Transaction History

Fosun International LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.13 - $3.69 $101,699 - $332,100	-90,000 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$2.85 - $3.73 $57,000 - $74,600	20,000 Added 28.57%	90,000 $293,000
Q4 2021 Feb 10, 2022	SELL	$3.24 - $5.18 $324,000 - $518,000	-100,000 Reduced 58.82%	70,000 $232,000
Q3 2021 Nov 12, 2021	BUY	$3.94 - $5.84 $669,800 - $992,800	170,000 New	170,000 $874,000
Q1 2021 May 11, 2021	SELL	$5.03 - $8.8 $301,800 - $528,000	-60,000 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$4.04 - $5.31 $242,400 - $318,600	60,000 New	60,000 $288,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.